SEC Form 4 · accession 0001140361-16-065230
MEDICINES CO /DE · MDCO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Fredric N Eshelman
Director
Period of report
May 12, 2016
Accepted (ET)
May 13, 2016 · 5:04 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001113481
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | May 12, 2016 | P | 300,000 | $33.68 | A | 300,000 | D | |
| Common StockF2 | holding | — | — | — | 944,537 | I | See footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents the weighted average purchase price of the shares purchased ranging from a low of $32.99 to a high of $33.94 per share. The reporting person undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- F2These shares of the issuer's common stock are owned by Eshelman Ventures, LLC, an entity wholly owned by the reporting person.